Recommended Citation
Jordan Paradise,
Reassessing Safety for Nanotechnology Combination Products: What do Biosimilars Add to Regulatory Challenges for the FDA,
56
St. Louis U. L.J.
(2012).
Available at:
https://scholarship.law.slu.edu/lj/vol56/iss2/5